SecurityIMPR / Imprivata Inc. (45323J103)
Institutional Owners0
Common Shares Outstanding25,573,159 shares (as of 2016-06-30)

Institutional Stock Ownership and Shareholders

IMPR / Imprivata Inc. Institutional Ownership

Imprivata Inc. (NYSE:IMPR) has 0 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .
Imprivata Inc. (NYSE:IMPR) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/impr"><img src="https://images.fintel.io/us-impr-so.png" alt="IMPR / Imprivata Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2016-11-08 13F-HR TEACHERS ADVISORS INC 25,445 0 -100.00 356 0 -100.00
2016-11-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 12,013 0 -100.00 168 0 -100.00
2016-11-14 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 43,198 0 -100.00 605 0
2016-11-14 13F-HR Capital World Investors 381,168 0 -100.00 5,336 0 -100.00
2016-11-08 13F-HR BlackRock Investment Management, LLC 61,024 0 -100.00 854 0 -100.00
2016-10-25 13F-HR/A CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 30,800 0 -100.00 4,312 0 -100.00
2016-11-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 9,215 0 -100.00 129,010 0 -100.00
2016-10-05 13F-HR BNP PARIBAS ARBITRAGE, SA 628 0 -100.00 8,792 0 -100.00
2016-11-09 13F-HR NORTHERN TRUST CORP 202,208 0 -100.00 2,831 0 -100.00
2016-11-14 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 24,800 0 -100.00 348 0 -100.00
2016-11-14 13F-HR DISCIPLINED GROWTH INVESTORS INC /MN 268,861 0 -100.00 3,764 0 -100.00
2016-11-10 13F-HR PARADIGM CAPITAL MANAGEMENT INC/NY 839,900 0 -100.00 11,758 0
2016-10-11 13F-HR Cutler Group LP 462 0 -100.00 6 0 -100.00
2016-11-14 13F-HR D. E. Shaw & Co., Inc. 376,281 0 -100.00 5,268 0 -100.00
2016-11-14 13F-HR TWO SIGMA INVESTMENTS LLC 43,701 0 -100.00 612 0 -100.00
2016-11-03 13F-HR Bank of New York Mellon Corp 47,854 0 -100.00 670 0 -100.00
2016-10-27 13F-HR STRS OHIO 44,000 0 -100.00 616 0 -100.00
2016-11-01 13F-HR ESSEX INVESTMENT MANAGEMENT CO LLC 42,516 0 -100.00 595 0 -100.00
2016-10-27 13F-HR EMERALD MUTUAL FUND ADVISERS TRUST 624,927 0 -100.00 8,749 0 -100.00
2016-11-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 100 0 -100.00 1 0
2017-01-13 13F-HR/A STATE STREET CORP 206,420 0 -100.00 2,892 0 -100.00
2016-11-08 13F-HR Tower Research Capital LLC (TRC) 740 0 -100.00 10 0 -100.00
2016-11-14 13F-HR WADDELL & REED FINANCIAL INC 389,600 0 -100.00 5,454 0 -100.00
2016-11-14 13F-HR VANGUARD GROUP INC 679,258 0 -100.00 9,510 0 -100.00
2016-10-12 13F-HR Creative Planning 200 0 -100.00 3 0 -100.00
2016-11-08 13F-HR RHUMBLINE ADVISERS 13,206 0 -100.00 185 0 -100.00
2016-11-09 13F-HR GLOBEFLEX CAPITAL L P 61 0 -100.00 1 0 -100.00
2016-11-14 13F-HR MENTA CAPITAL LLC 36,973 0 -100.00 518 0 -100.00
2016-11-14 13F-HR BARCLAYS PLC 3,300 0 -100.00 46 0
2016-11-10 13F-HR CITIGROUP INC 1,096 0 -100.00 15 0 -100.00
2016-11-10 13F-HR GEODE CAPITAL MANAGEMENT, LLC 92,428 0 -100.00 1,293 0 -100.00
2017-02-15 SC 13G/A RGM Capital, LLC 0 0 -100.00 0 0 -100.00
2016-11-14 13F-HR Renaissance Technologies LLC 377,700 0 -100.00 5,288 0
2016-11-14 13F-HR DEUTSCHE BANK AG\ 185,827 0 -100.00 2,601 0 -100.00
2016-11-10 13F-HR MORGAN STANLEY 25,025 0 -100.00 350 0 -100.00
2016-10-27 13F-HR EMERALD ADVISERS INC/PA 630,614 0 -100.00 8,829 0 -100.00
2016-10-20 13F-HR Nationwide Fund Advisors 10,261 0 -100.00 144 0 -100.00
2016-10-13 13F-HR Profit Investment Management, LLC 131,972 0 -100.00 1,848 0 -100.00
2016-11-10 13F-HR CITADEL ADVISORS LLC 14,498 0 -100.00 203 0 -100.00
2017-01-24 13F-HR/A Allianz Asset Management AG 186,503 0 -100.00 3,314 0 -100.00
2016-11-14 13F-HR BANK OF AMERICA CORP /DE/ 302 0 -100.00 4 0
2016-11-14 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 12,148 0 -100.00 170 0 -100.00
2016-11-14 13F-HR/A Pine River Capital Management L.P. 0 0 0.00 0 0
2016-11-10 13F-HR Carleon Capital Partners LLC 24,823 0 -100.00 348 0 -100.00
2016-11-14 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 13,187 0 -100.00 185 0 -100.00
2016-11-08 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 16,400 0 -100.00 230 0 -100.00
2016-11-10 13F-HR BROADWOOD CAPITAL INC 737,911 0 -100.00 10,331 0 -100.00
2016-10-26 13F-HR MAGEE THOMSON INVESTMENT PARTNERS LLC 81 0 -100.00 1 0 -100.00
2016-11-08 13F-HR BlackRock Institutional Trust Company, N.A. 275,699 0 -100.00 3,860 0 -100.00
2016-11-14 13F-HR Invesco Ltd. 11,939 0 -100.00 167 0 -100.00
2016-11-14 13F-HR Wellington Management Group LLP 3,449,840 0 -100.00 48,298 0 -100.00
2016-11-14 13F-HR WALL STREET ASSOCIATES 195,800 0 -100.00 2,741 0
2016-11-10 13F-HR Laurion Capital Management LP 429,600 0 -100.00 6,014 0
2016-11-01 13F-HR GILDER GAGNON HOWE & CO LLC 257,180 0 -100.00 3,601 0 -100.00
2016-11-14 13F-HR TWO SIGMA ADVISERS, LP 54,000 0 -100.00 756 0 -100.00
2016-11-09 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 33,567 0 -100.00 470 0 -100.00
2016-11-08 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 45,557 0 -100.00 638 0 -100.00
2016-11-14 13F-HR MILLENNIUM MANAGEMENT LLC 24,600 0 -100.00 344 0 -100.00
2016-11-02 13F-HR Tygh Capital Management, Inc. 44,843 0 -100.00 628 0 -100.00
2016-11-08 13F-HR BlackRock Fund Advisors 412,719 0 -100.00 5,778 0 -100.00
2016-11-14 13F-HR UBS Group AG 1,188 0 -100.00 17 0 -100.00
2017-02-13 SC 13G/A General Catalyst Group II, L.P. 2,548,413
2016-11-14 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 23,839 0 -100.00 334 0 -100.00
2016-11-08 13F-HR BlackRock Advisors LLC 4,665 0 -100.00 65 0 -100.00
2016-11-14 13F-HR PDT Partners, LLC 12,500 0 -100.00 175 0
2017-02-15 SC 13G/A Tamarack Advisers, LP 1,746,000 0 -100.00 0 -100.00
2016-11-08 13F-HR BlackRock Inc. 658 0 -100.00 9 0 -100.00
2016-10-31 13F-HR WELLS FARGO & COMPANY/MN 163,608 0 -100.00 2,291 0 -100.00

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 45323J103